» Authors » Serkan Karakus

Serkan Karakus

Explore the profile of Serkan Karakus including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karakus S, Unal S, Dai D, Joseph C, Du Comb W, Levy J, et al.
J Sex Med . 2024 Jul; 21(8):716-722. PMID: 38971577
Background: Peyronie's disease (PD) is a connective tissue disorder that affects the penis and is characterized by abnormal collagen structure in the penile tunica albuginea, resulting in plaque formation and...
2.
Unal S, Karakus S, Du Comb W, Burnett A
J Sex Med . 2024 Jul; 21(8):723-728. PMID: 38971576
Background: Major ischemic priapism (IP) is defined as a persistent penile erection for >4 hours. IP may cause serious complications, especially if prompt resolution is not achieved. Therefore, selecting the...
3.
Sturny M, Karakus S, Fraga-Silva R, Stergiopulos N, Burnett A
J Sex Med . 2022 Mar; 19(5):686-696. PMID: 35288047
Background: Neurogenic erectile dysfunction (ED) following radical prostatectomy (RP) is a frequent complication often leading to erectile tissue remodeling and permanent ED. Low-intensity electrostimulation (LIES) has been shown to enhance...
4.
Kaya M, Karakus S, Tuncer S
Comput Methods Programs Biomed . 2021 Dec; 214:106525. PMID: 34852958
Objective: In this study, it is aimed to detect ataxia for Persons with Multiple Sclerosis (PwMS) through a deep learning-based approach using an image dataset containing static plantar pressure distribution....
5.
Campbell J, Chan E, Di Pierdominico A, Karakus S, Trock B, Brock G, et al.
Can Urol Assoc J . 2021 Sep; 16(2):42-46. PMID: 34582341
Introduction: Inflatable penile prosthesis (IPP) implantation is the gold standard treatment for medically refractory erectile dysfunction. New chronic pain after IPP implantation is rarely discussed and the optimal treatment is...
6.
Karakus S, Musicki B, Burnett A
Int J Impot Res . 2021 Jul; 34(6):588-592. PMID: 34215861
Phosphodiesterase type 5 inhibitors (PDE5i) is the only approved oral treatment for erectile dysfunction (ED) in the US, and alternative management remains necessary when this treatment fails or is contraindicated....
7.
Musicki B, Karakus S, La Favor J, Chen H, Silva F, Sturny M, et al.
J Cell Physiol . 2020 Sep; 236(4):3073-3082. PMID: 32974910
Priapism, a prolonged penile erection in the absence of sexual arousal, is common among patients with sickle cell disease (SCD). Hypogonadism is also common in patients with SCD. While the...
8.
Karakus S, Burnett A
Can J Urol . 2020 Sep; 27(S3):28-35. PMID: 32876000
Introduction: Erectile dysfunction (ED) is a common condition affecting more than 3 million men in the United States every year. Given the prevalence of severe co-morbidities associated with ED, the...
9.
Kang J, Le H, Karakus S, Malla A, Harraz M, Kang J, et al.
Sci Rep . 2020 Apr; 10(1):6618. PMID: 32313132
Despite current progress achieved in the surgical technique of radical prostatectomy, post-operative complications such as erectile dysfunction and urinary incontinence persist at high incidence rates. In this paper, we present...
10.
Karakus S, Musicki B, Navati M, Friedman J, Davies K, Burnett A
J Pharmacol Exp Ther . 2020 Mar; 373(2):214-219. PMID: 32144123
Sickle cell disease (SCD) is associated with overactive bladder (OAB). Detrusor overactivity, a component of OAB, is present in an SCD mouse, but the molecular mechanisms for this condition are...